InsidersTradesSigma
東和薬品株式会社 Stock: price and management transactions · Japan · EDINET (Japan FSA)
Follow the 東和薬品株式会社 share price and the full management transaction log of the company, a listed equity based in Japan. Shares are quoted on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 東和薬品株式会社 has published 3 insider filings. Market capitalisation: €199.9bn. The latest transaction was disclosed on 6 July 2026 (Holding update). Among the most active insiders: Sumitomo Mitsui DS Asset Management Company, Limited. All data is openly available.
3
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 東和薬品株式会社 Strong Buy (bullish), based on 6 analysts. Average price target: JP¥5,250.
21Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 16,406 of 25,821 companies
43.4
score / 100
Value52
Quality35
FCF yld3.2%
Earn yld2.6%
EV/EBITDA11.1x
ROE3.0%
Gross mgn36%
Net mgn1.9%
Debt/EBITDA5.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 July 2026
Declarations3 total
ShareXTKSEDINET:S100YOTO
ShareXTKSEDINET:S100XJ2X
100.0% of flowShareXTKSEDINET:S100QTZZ
3 of 3 declarations
About 東和薬品株式会社
Towa Pharmaceutical Co., Ltd. is a Japanese company specializing in the pharmaceutical sector. It focuses on the research, development, and marketing of medications.